A detailed history of Cgc Financial Services, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cgc Financial Services, LLC holds 507 shares of ABT stock, worth $59,689. This represents 0.02% of its overall portfolio holdings.

Number of Shares
507
Previous 298 70.13%
Holding current value
$59,689
Previous $31 Million 86.67%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $20,914 - $24,689
209 Added 70.13%
507 $57.8 Million
Q2 2023

Sep 12, 2023

BUY
$100.78 - $112.29 $30,032 - $33,462
298 New
298 $32.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cgc Financial Services, LLC Portfolio

Follow Cgc Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cgc Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cgc Financial Services, LLC with notifications on news.